Kingdon Capital Management, L.L.C. Haemonetics Corp Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $9.17 Million - $10.4 Million	111,100 New	111,100 $9.95 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $3.64 Million - $4.53 Million	50,000 New	50,000 $4.14 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $4.71 Million - $6.31 Million	95,500 New	95,500 $6.23 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $5.91 Million - $8.53 Million	-135,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $1.73 Million - $2.61 Million	35,000 Added 35.0%	135,000 $7.16 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $5.76 Million - $7.06 Million	100,000 New	100,000 $7.06 Million

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.56B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.